v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04596839 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : June 3, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : June 3, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
aziz100542@yahoo.com |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-10-22 |
Recruitment status
Last imported at : Aug. 11, 2021, 4 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: age ≥18 years at time of signing informed consent form hospitalized with diagnosed covid-19 confirmed by rt-pcr test ≤ 7 days before randomization with any one following criteria respiratory distress (≥30 breaths/min); finger oxygen saturation ≤93% at rest; arterial partial pressure of oxygen (pao2)/fraction of inspired oxygen (fio2) ≤300mmhg willingness of study participant to accept randomization to any assigned treatment arm must agree not to enroll in another study of an investigational agent prior to completion of day 28 of study |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
- physician makes a decision that trial involvement is not in patients' best interest, or any condition that does not allow the protocol to be followed safely. - severe liver disease (alanine transaminase (alt) or aspartate transaminase (ast) > 5 times the upper limit of normal) - estimated glomerular filtration rate (egfr) < 30 ml/min (including patients receiving hemodialysis or hemofiltration). - mechanically ventilated (including v-v ecmo) ≥ 5 days, or any duration of v-a ecmo. - known hypersensitivity to the remdesivir, the metabolites, or formulation excipient - pregnancy or breast feeding. - anticipated discharge from the hospital or transfer to another hospital which is not a study site within 72 hours. |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Dr. Md. Alimur Reza |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Bangladesh |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Severe disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
6: Severe disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
60 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Duration of hospital stay (Days) |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : June 3, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : Oct. 29, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |